Recognition of Granzyme B‐generated autoantigen fragments in scleroderma patients with ischemic digital loss

Abstract

The striking recognition of GB-generated autoantigen fragments by sera from patients with limited SSc and IDL constitutes the first in vivo evidence that antibodies against GB-generated centromeric peptide fragments identify a distinct clinical subset.